{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:40:27Z","timestamp":1790671227653,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>It is of international priority to develop a vaccine against sexually transmitted<jats:italic>Chlamydia trachomatis<\/jats:italic>infections to combat the continued global spread of the infection. The optimal immunization strategy still remains to be fully elucidated. The aim of this study was to evaluate immunization strategies in a nonhuman primate (NHP) model. Cynomolgus macaques (<jats:italic>Macaqua fascicularis<\/jats:italic>) were immunized following different multi-component prime-boost immunization-schedules and subsequently challenged with<jats:italic>C. trachomatis<\/jats:italic>SvD in the lower genital tract. The immunization antigens included the recombinant protein antigen CTH522 adjuvanted with CAF01 or aluminium hydroxide, MOMP DNA antigen and MOMP vector antigens (HuAd5 MOMP and MVA MOMP). All antigen constructs were highly immunogenic raising significant systemic<jats:italic>C. trachomatis<\/jats:italic>-specific IgG responses. In particularly the CTH522 protein vaccinated groups raised a fast and strong pecificsIgG in serum. The mapping of specific B cell epitopes within the MOMP showed that all vaccinated groups, recognized epitopes near or within the variable domains (VD) of MOMP, with a consistent VD4 response in all animals. Furthermore, serum from all vaccinated groups were able to<jats:italic>in vitro<\/jats:italic>neutralize both SvD, SvE and SvF. Antibody responses were reflected on the vaginal and ocular mucosa, which showed detectable levels of IgG. Vaccines also induced<jats:italic>C. trachomatis-<\/jats:italic>specific cell mediated responses, as shown by<jats:italic>in vitro<\/jats:italic>stimulation and intracellular cytokine staining of peripheral blood mononuclear cells (PBMCs). In general, the protein (CTH522) vaccinated groups established a multifunctional CD4 T cell response, whereas the DNA and Vector vaccinated groups also established a CD8 T cells response. Following vaginal challenge with<jats:italic>C. trachomatis<\/jats:italic>SvD, several of the vaccinated groups showed accelerated clearance of the infection, but especially the DNA group, boosted with CAF01 adjuvanted CTH522 to achieve a balanced CD4\/CD8 T cell response combined with an IgG response, showed accelerated clearance of the infection.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1057375","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:28:28Z","timestamp":1669177708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model"],"prefix":"10.3389","volume":"13","author":[{"given":"Emma","family":"Lorenzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja W.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Rosenkrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene B\u00e6k","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Delache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delaugerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dereuddre-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9b\u00e9ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertille","family":"De Barbeyrac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabella","family":"Touati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/jcpa.2002.0629","article-title":"Animal chlamydioses and zoonotic implications","volume":"128","author":"Longbottom","year":"2003","journal-title":"J Comp Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1086\/652395","article-title":"Risk of sequelae after chlamydia trachomatis genital infection in women","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.032","article-title":"Current barriers, challenges and opportunities for the development of effective STI vaccines: point of view of vaccine producers, biotech companies and funding agencies","volume":"32","author":"Dodet","year":"2014","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.3.1491-1494.1983","article-title":"Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix","volume":"39","author":"Brunham","year":"1983","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4704-4714.1995","article-title":"Protective efficacy of major outer membrane protein-specific immunoglobulin a (IgA) and IgG monoclonal antibodies in a murine model of chlamydia trachomatis genital tract infection","volume":"63","author":"Cotter","year":"1995","journal-title":"Infect Immun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1997.d01-167.x","article-title":"Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans","volume":"46","author":"Johansson","year":"1997","journal-title":"Scand J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103032","article-title":"CD4+ T cells are necessary and sufficient to confer protection against chlamydia trachomatis infection in the murine upper genital tract","volume":"189","author":"Gondek","year":"2012","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12317","article-title":"Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections","volume":"143","author":"Armitage","year":"2014","journal-title":"Immunology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2013.110","article-title":"Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens","volume":"92","author":"Armitage","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790463","article-title":"Th1\/Th17 T cell tissue-resident immunity increases protection, but is not required in a vaccine strategy against genital infection with chlamydia trachomatis","volume":"12","author":"Nguyen","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0157-x","article-title":"Parenteral vaccination protects against transcervical infection with chlamydia trachomatis and generate tissue-resident T cells post-challenge","volume":"5","author":"Nguyen","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00162","article-title":"A multi-component prime-boost vaccination regimen with a consensus MOMP antigen enhances chlamydia trachomatis clearance","volume":"7","author":"Badamchi-Zadeh","year":"2016","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0141209","DOI":"10.1371\/journal.pone.0141209","article-title":"Intramuscular immunisation with chlamydial proteins induces chlamydia trachomatis specific ocular antibodies","volume":"10","author":"Badamchi-Zadeh","year":"2015","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1415684","article-title":"Adjuvanted influenza vaccines","volume":"14","author":"Tregoning","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.0019-2805.2001.01354.x","article-title":"Fc receptor regulation of protective immunity against chlamydia trachomatis","volume":"105","author":"Moore","year":"2002","journal-title":"Immunology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.125","article-title":"Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of chlamydia","volume":"9","author":"O\u2019Meara","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01652","article-title":"Protective effect of vaccine promoted neutralizing antibodies against the intracellular pathogen chlamydia trachomatis","volume":"8","author":"Olsen","year":"2017","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(97)00206-5","article-title":"Monoclonal immunoglobulin a antibody to the major outer membrane protein of the chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge","volume":"15","author":"Pal","year":"1997","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1086\/652400","article-title":"Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies","author":"Batteiger","year":"2010","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3302-3308.1995","article-title":"CD4+ T cells play a significant role in adoptive immunity to chlamydia trachomatis infection of the mouse genital tract","volume":"63","author":"Su","year":"1995","journal-title":"Infect Immun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00191-20","article-title":"Gamma interferon is required for chlamydia clearance but is dispensable for T cell homing to the genital tract","volume":"11","author":"Helble","year":"2020","journal-title":"mBio"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900295","article-title":"T Cell responses in the absence of IFN-gamma exacerbate uterine infection with chlamydia trachomatis","volume":"183","author":"Gondek","year":"2009","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.05022-11","article-title":"Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital chlamydia muridarum infection","volume":"79","author":"Murthy","year":"2011","journal-title":"Infect Immun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.74","article-title":"The contribution of chlamydia-specific CD8(+) T cells to upper genital tract pathology","volume":"94","author":"Vlcek","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1086\/605411","article-title":"Role of T lymphocytes in the pathogenesis of chlamydia disease","volume":"200","author":"Igietseme","year":"2009","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00145-19","article-title":"Chlamydia muridarum induces pathology in the female upper genital tract via distinct mechanisms","volume":"87","author":"Yu","year":"2019","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.63.2.516-521.1995","article-title":"Role of CD8 T cells in primary chlamydia infection","volume":"63","author":"Magee","year":"1995","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400120","article-title":"CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against chlamydia trachomatis infection in macaques","volume":"192","author":"Olivares-Zavaleta","year":"2014","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e5139","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4 and CD8 T cell responses to the m. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"4","author":"Elvang","year":"2009","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin a and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00219-9","article-title":"Vaccination of mice with DNA plasmids coding for the chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge","volume":"17","author":"Pal","year":"1999","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633776","article-title":"A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: From basic principles to current applications","volume":"9","author":"Qin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/675360","article-title":"Nonhuman primate models used to study pelvic inflammatory disease caused by chlamydia trachomatis","volume":"2011","author":"Bell","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00984-06","article-title":"Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations","volume":"51","author":"Patton","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.6.2175-2182.1997","article-title":"Repeated chlamydia trachomatis infection of macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring","volume":"65","author":"Van Voorhis","year":"1997","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jprot.2014.05.009","article-title":"Whole genome identification of c. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques","volume":"108","author":"Patton","year":"2014","journal-title":"J Proteomics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from m. tuberculosis (trehalose 6,6\u2019-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/iai.31.3.1161-1176.1981","article-title":"Purification and partial characterization of the major outer membrane protein of chlamydia trachomatis","volume":"31","author":"Caldwell","year":"1981","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.415","article-title":"Workshop on in vitro neutralization of chlamydia trachomatis: summary of proceedings","volume":"168","author":"Byrne","year":"1993","journal-title":"J Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1057375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T16:18:53Z","timestamp":1678724333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1057375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2022.1057375"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1057375","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"article-number":"1057375"}}